Prime Medicine: Funding, Investors & Team (Sep 2026)
Prime Medicine specializes in creating gene editing treatments using Prime Editing technology, which allows for precise correction of genetic mutations without causing double-strand breaks in the DNA. This provides an alternative to traditional CRISPR methods and makes it possible to target a wide range of mutations across various organ systems. The company's pipeline includes therapies for liver, eye, blood, and central nervous system disorders, using their unique delivery platforms and screening tools to improve the accuracy and longevity of gene edits. Their goal is to translate advancements in genome editing into effective clinical treatments that have the potential to cure diseases with just a single treatment.
Prime Medicine has raised $224M across 2 funding rounds on record, the most recent an undisclosed round of $24.0M announced in Jul 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Prime Medicine Company Profile and Key Stats
Latest funding round on record: Jul 2025.
Prime Medicine Funding Rounds
Prime Medicine raised $200M in a Series B announced in Jul 2021.
4 years later, an undisclosed round of $24.0M was announced in Jul 2025.
Prime Medicine Founders and Leadership Team
Contact details for the Prime Medicine team: 1 of 2 have an email address on file.
Start 14-day free trial →Prime Medicine Funding Compared to Other Biotechnology Startups
Prime Medicine's latest round of $24.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Prime Medicine in Biotechnology and Cambridge
Companies Similar to Prime Medicine
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Prime Medicine Funding FAQs
What does Prime Medicine do?
Prime Medicine specializes in creating gene editing treatments using Prime Editing technology, which allows for precise correction of genetic mutations without causing double-strand breaks in the DNA. This provides an alternative to traditional CRISPR methods and makes it possible to target a wide range of mutations across various organ systems. The company's pipeline includes therapies for liver, eye, blood, and central nervous system disorders, using their unique delivery platforms and screening tools to improve the accuracy and longevity of gene edits. Their goal is to translate advancements in genome editing into effective clinical treatments that have the potential to cure diseases with just a single treatment.
How much funding has Prime Medicine raised?
Prime Medicine has raised $224M across 2 rounds on record. The most recent is an undisclosed round of $24.0M announced in Jul 2025.
When did Prime Medicine last raise funding?
Prime Medicine's most recent funding round on record is an undisclosed round of $24.0M, announced in Jul 2025.
Who founded Prime Medicine?
FundedIQ lists Andrew Anzalone (Founder) at Prime Medicine.
Who is the CEO of Prime Medicine?
Keith Gottesdiener is listed as CEO at Prime Medicine.
Where is Prime Medicine headquartered?
Prime Medicine is based in Cambridge, Massachusetts, United States.
How many employees does Prime Medicine have?
Prime Medicine is in the 251-500 employee band.
How does Prime Medicine's funding compare to other Biotechnology startups?
Prime Medicine's latest round of $24.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Prime Medicine Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Prime Medicine is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.